Omnicell IncOMCL
Price$33.44Intrinsic value$46.2338% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.2B+12.1% YoYTTM through 30 Jun 2026
Net Income $39.1M+211.9% YoYTTM through 30 Jun 2026
Free Cash Flow $142.6MTTM through 30 Jun 2026

Margins

Current
Gross Margin43.6%
EBITDA Margin10.8%
Operating Margin5.5%
Net Margin3.1%

Returns

1.6%ROE
1.0%ROA
1.4%ROIC

Balance Sheet Health

Debt / Equity0.14x
Current Ratio1.50x
Net Debt-$71.2Mnet cash position
Cash & Equivalents$292.2M

Quality Metrics

Altman Z-Score2.47
Piotroski F-Score8 / 9
FCF Margin11.4%
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $1.2B
Diluted EPS$0.84TTM
'19'20'21'22'23'24'25
FY2025: $0.04

Dividend

No dividend

Capital Allocation

R&D Spend$88.4M
Capex Intensity3.1%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.